Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.
Sam de Costa
Advertisement
Articles by Sam de Costa
FDA approved the Raplixa, the first spray-dried fibrin sealant, in May 2015 to help control bleeding in adults during surgery.
Advertisement
Latest Updated Articles
Breaking the Cold Chain for VaccinesMay 15th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
5